BNP Paribas Financial Markets
AEON.WS

BNP Paribas Financial Markets’s AEON Biopharma Inc AEON.WS Stock Holding History

BNP Paribas Financial Markets’s Portfolio AEON.WS Stock Details AEON.WS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-115,714
Closed -$10.4K – 4065
2023
Q2 		$10.4K Hold
115,714
– – ﹤0.01% 3628
2023
Q1 		$6.36K Hold
115,714
– – ﹤0.01% 3571
2022
Q4 		$5.28K Buy
+115,714
New +$4.67K ﹤0.01% 3664

Other funds holding AEON.WS

AC
Athos Capital Hong Kong $324M AUM 16.62% 1-Year Est. Return
SCM
Shaolin Capital Management Miami, Florida $2.71B AUM 64.57% 1-Year Est. Return
CF
Cantor Fitzgerald New York $6.78B AUM 28.97% 1-Year Est. Return
AC
Aristeia Capital Greenwich, Connecticut $4.82B AUM 24.91% 1-Year Est. Return
DKCM
Davidson Kempner Capital Management New York $7.33B AUM 56.47% 1-Year Est. Return
RCM
Radcliffe Capital Management Bala Cynwyd, Pennsylvania $1.33B AUM 1.18% 1-Year Est. Return
LP
LMR Partners London, United Kingdom $45.4B AUM 60.47% 1-Year Est. Return
CAC
Cowen and Company New York $2.97B AUM 105.26% 1-Year Est. Return
TCM
Tenor Capital Management New York $6.49B AUM 3% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

BNP Paribas Financial Markets's AEON.WS Position: Q3 2023 in Review

BNP Paribas Financial Markets sold out of AEON Biopharma Inc (AEON.WS) in Q3 2023, closing a stake of 115,714 shares — an estimated $10.4K sold.

BNP Paribas Financial Markets first reported a position in AEON.WS in Q4 2022 and held it in 3 quarters. The position peaked at $10.4K in Q2 2023. 40 funds tracked by Wall St. Rank hold AEON.WS as of Q3 2023.

  • BNP Paribas Financial Markets reported no remaining AEON Biopharma Inc position as of Q3 2023 after selling out during the quarter.
  • BNP Paribas Financial Markets sold 115,714 AEON Biopharma Inc shares in Q3 2023, an estimated $10.4K.
  • BNP Paribas Financial Markets first reported a position in AEON Biopharma Inc in Q4 2022 and held it in 3 quarters.
  • BNP Paribas Financial Markets's AEON Biopharma Inc position peaked at $10.4K in Q2 2023.
  • 40 funds tracked by Wall St. Rank held AEON Biopharma Inc as of Q3 2023.

Based on BNP Paribas Financial Markets's 13F filing for Q3 2023, filed 14 Nov 2023.